Janux Therapeutics JANX Q1 2025 earnings
Reported May 8, 2025 · Before market open
Revenue-
EPS-$0.38Beat by $0.05
EPS estimate-$0.43
Next report
Aug 6, 2026 (In 1 week)Revenue estimate$19.1M
EPS estimate-$0.26
Financials
Q1 2025Valuation & ratios
Versus estimates
Ask the moment Janux Therapeutics reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Janux Therapeutics report Q1 2025 earnings?
- Janux Therapeutics (JANX) reported Q1 2025 earnings on May 8, 2025 before market open.
- What were Janux Therapeutics's Q1 2025 revenue and EPS?
- Janux Therapeutics reported revenue of - and eps of $-0.38 for Q1 2025.
- Did Janux Therapeutics beat estimates in Q1 2025?
- EPS beat the consensus estimate of $-0.43 by $0.05.
- How did Janux Therapeutics's Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 100.0% from $1.3M a year earlier and eps declined 26.7% from $-0.30.
- Where can I find Janux Therapeutics's Q1 2025 SEC filings?
- You can read the 10-Q periodic report (0000950170-25-067083) directly on SEC EDGAR. The filing index links above go to sec.gov.